Issue 59 – October 2017
Pictured above are Nancy Bryan, Jane Teague, Todd Andersen-Davis, Dr. Kevin Krenitsky and Valerie McDevitt.
Companies Compete for Top Honor at BioFlorida’s 20th Anniversary Conference
Winner of BioPitch Announced at Closing Session
Seed and early stage companies participated in the BioPitch competition at the BioFlorida 20th
Anniversary Conference which took place October 15 - 17 in St. Petersburg. BioPitch provides participants with opportunities for coaching as well as presentations to investors for feedback and potential funding. Fifteen companies participated in closed-door sessions on Monday afternoon, and the four semi-finalists included Alertgy
(Daytona Beach), FloSpine
(Boca Raton), Interpares Biomedicine
(Land O’Lakes) and Jupiter Orphan Technologies
(Jupiter). Each company presented at the General Session on Tuesday, with Interpares Biomedicine, an early-stage medical therapeutics company focused on providing personalized medicine solutions to inform cancer immunotherapy decisions, receiving top recognition.
Biscayne Neurotherapeutics Reports Successful Phase 1b Clinical Trial Results for its Novel Antiepileptic Agent
Biscayne Neurotherapeutics, a clinical-stage company developing novel agents for the treatment of neurological disorders, announced results from a Phase 1b trial of its novel antiepileptic compound, BIS-001ER. In the trial, the new extended release version of BIS-001 has met or surpassed all pre-defined endpoints. More details may be viewed here.
Tallahassee Research Centers Advancing Innovation, Commercialization
Entrepreneur-In-Residence, Lawrence Tinker, PhD, was featured in the Tallahassee Democrat in an article focused on the impact of innovation in the region and across the state. More details may be viewed here.
Pictured above are Dr. Daniel Flynn, Sharon Evans, Dr. Eytan Gilboa, Jane Teague, Ido Sivan-Sevilla, and Lauren Nemerovski.
Florida Institute, FAU Tech Runway, and Research Park at FAU Host Session on Cybersecurity and Digital Diplomacy
On October 18th
, three South Florida entities collaborated to host speakers from the Israel Public Diplomacy Forum. Dr. Eytan Gilboa and Mr. Ido Sivan-Sevilla joined attendees at FAU Tech Runway to discuss ever-evolving cybersecurity threats and new strategies to prevent attacks, within the context of digital diplomacy. The session was part of a weeklong dialogue that featured presentations across the Palm Beach region on related topics. The Israel Public Diplomacy Forum
is a non-profit, non-partisan, educational organization established to advance international understanding of Israel and the Middle East. More details about the Research Park at FAU and FAU Tech Runway may be viewed in the links below:
Closing Keynote Panel Announced for SEBIO Investor and Partnering Forum
Venture capital continues to play a critical role in financing innovation in the life sciences. The Southeast BIO Investor and Partnering Forum will feature a panel of prominent industry investors on November 16, 2017 in Pinehurst, NC. The panel will focus on current trends, including the unprecedented amount of capital currently flowing into the industry and the state of the public markets. More details about the conference may be viewed here
Gulf Power Hosts 21st Annual Economic Symposium at Sandestin Golf and Beach Resort
Application Deadline for 2018 Florida Venture Forum Capital Conference Extended to December 20, 2017
The Florida Venture Forum is accepting applications to present at the 2018 conference, and early submissions are welcomed and encouraged as a limited number of presenter spots are available. The deadline to submit is December 20, 2017. These applications will be reviewed by a selection committee comprised of venture capitalists and private equity investors. If selected, presenting companies will be charged $599 for their first conference attendee and a $50 exhibit fee. To ensure optimum coverage, there is a discounted fee of $399 per additional attendee from the presenting company. More details and the application may be viewed here.
Formed by the Florida Legislature in 2007, the Florida Institute for the Commercialization of Public Research
is a non-profit organization that works collaboratively with the technology licensing and commercialization offices of Florida’s state universities and private research institutions to leverage a $2.5B+ research base and form investable companies that create clean jobs in new industries that are driving the global economy. The Institute provides company building services, and seed funding through the Florida Technology Seed Capital Fund, to promising Florida startups. Seventy-two companies have been funded to date, and the Institute’s economic impact through June 30, 2017 was $970 million, with an annual return on investment of 26 times to the State of Florida.